Article

Smokers appear to have greater risk and faster progression of AMD

Smokers have an increased long-term risk and greater progression of age-related macular degeneration (AMD).

Beaver Dam, WI-Smokers have an increased long-term risk and greater progression of age-related macular degeneration (AMD), according to a study in the January issue of Archives of Ophthalmology.

Smoking had already been identified as one of the risk factors for AMD, according to the study. Smoking may contribute to AMD by reducing antioxidant levels, decreasing blood flow around the eye, or affecting the pigments in the retina.

Ronald Klein, MD, MPH, and colleagues at the University of Wisconsin School of Medicine and Public Health, Madison, studied 4,926 residents of Beaver Dam, WI, who were ages 43 to 84 years in 1987 to 1988. They were initially examined in 1988 to 1990 and were re-examined every 5 years for the next 15 years.

At the beginning of the study, 21% of the men and 18% of the women in the study were smokers. Smokers had a 47% increase in their odds of developing early AMD. Smokers also developed AMD at a younger age (69.2 years) than former smokers (72.3 years) and those who had never smoked (74.4 years).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.